Prime Medicine (PRME) Current Leases (2021 - 2026)
Prime Medicine (PRME) posted Current Leases of $8.5 million for Q1 2026, up 5.03% on a QoQ basis from $8.1 million in Q4 2025, and up 24.61% year-over-year from $6.9 million in Q1 2025.
Prime Medicine (PRME) Current Leases (2021 - 2026) Analysis & Trends
Prime Medicine's Current Leases history runs 6 years deep, the most recent figure standing at $8.5 million for Q1 2026.
- Quarterly Current Leases rose 24.61% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (up 24.61% YoY) and the FY2025 annual result came in at $8.1 million, up 125.15% from the prior year.
- Current Leases was $8.5 million for Q1 2026 at Prime Medicine, up from $8.1 million in the prior quarter.
- Across five years, Current Leases topped out at $13.5 million in Q2 2023 and bottomed at $3.6 million in Q4 2024.
- A 5-year average of $8.5 million and a median of $8.1 million in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases slumped 61.39% — and 2025, when it jumped 125.15%.
- Prime Medicine's Current Leases stood at $11.7 million in 2022, then fell by 20.68% to $9.3 million in 2023, then plunged by 61.04% to $3.6 million in 2024, then soared by 125.15% to $8.1 million in 2025, then rose by 5.03% to $8.5 million in 2026.
- Business Quant data shows PRME's Current Leases at $8.5 million in Q1 2026, $8.1 million in Q4 2025, and $7.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Prime Medicine | 525.98 Mn | 525.98 Mn | - | 8.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.55 Mn |
| Dec 31, 2025 | 8.14 Mn |
| Sep 30, 2025 | 7.71 Mn |
| Jun 30, 2025 | 7.26 Mn |
| Mar 31, 2025 | 6.86 Mn |
| Dec 31, 2024 | 3.61 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Jun 30, 2024 | 5.22 Mn |
| Mar 31, 2024 | 6.75 Mn |
| Dec 31, 2023 | 9.28 Mn |
| Sep 30, 2023 | 11.22 Mn |
| Jun 30, 2023 | 13.51 Mn |
| Mar 31, 2023 | 11.77 Mn |
| Dec 31, 2022 | 11.69 Mn |
| Sep 30, 2022 | 11.58 Mn |
| Dec 31, 2021 | 7.34 Mn |